Everest Medicines has dosed the first subject with EVM16, the company’s personalised messenger ribonucleic acid (mRNA) cancer ...

This study introduces a deep-learning system for rapid, automated detection and classification of tiny calcium deposits ...

Each year, millions of women undergo mammography to screen for breast cancer, yet tiny calcium specks—known as microcalcifications—often evade detection or are misread, leading to delayed diagnoses or ...

of the Fudan University Shanghai Cancer Center and principal investigator of the clinical trials, said in a press release from Akeso, the drug’s maker. The FDA’s decision was based on ...